Organization
Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC)
2 abstracts
Abstract
Non-basal subtype defined by FOXC1 expression as an independent predictor of capecitabine efficacy in the triple negative breast cancer GEICAM/2003-11_CIBOMA/2004-01 trial.Org: Onconostic Technologies, Evanston, IL, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Instituto Nacional de Enfermedades Neoplásicas (INEN), Universidad Ricardo Palma, Instituto Nacional del Cáncer; LACOG (Latin American Cooperative Oncology Group), Hospital Amaral Carvalho; LACOG (Latin American Cooperative Oncology Group),
Abstract
Association of encapsulation of CDK12 inhibitor with anti-tumour activity in colon cancer cell lines.Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Hospital Universitario Clínico San Carlos, Hospital Clínico San Carlos, Hospital Clínico San Carlos and IdISSC, Madrid, Spain, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC),